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A 21-year-old Indonesian male presented with a 6-month 
history of abdominal pain. The pain was described as a diffuse 
cramping that was worse with movement and after meals. 
He reported early satiety, and the pain was improved at rest. 
Associated with the pain, he reported a seventy pound weight 
loss, chills, decreased energy, and fatigue over the same time 
period. He denied nausea, vomiting, fevers, cough, dyspnea, or 
chest pain.
The patient emigrated from Indonesia to the United States in 
2007 and has since had no travel or foreign visitors. He denied 
incarceration or military duty for both himself and close 
relatives. There was no prior  purified protein derivative (PPD) 
placement or Bacille Calmette Guerin (BCG) vaccination.
The patient was seen at a different hospital approximately one 
month prior for a subcutaneous mass in his right lateral neck 
that had been present for two years. At that time, the mass was 
diagnosed as a simple cyst on imaging; no fluid aspiration or 
biopsy was performed. During the month that elapsed before 
presentation to our hospital, the patient reported the mass 
spontaneously drained yellow fluid and dramatically reduced 
in size.
On examination, he was afebrile and in no distress, but he 
appeared cachectic and older than his stated age. There was a 
right supraclavicular indurated healed scar without fluctuance 
or discharge. The patient had clear lungs to auscultation. On 
abdominal exam, he had loose skin with pale striae, normal bowel 
sounds, and a soft non-distended abdomen with tenderness to 
palpitation in the lower quadrants. There was mild guarding, 
but no rebound, hepatosplenomegaly, or bulging flanks. 
Initial blood work was significant for a normocytic anemia, with 
a hemoglobin of 12.4 g/dL, a mean cell volume of 81 fL, platelet 
count of 410 B/L, and a mildly elevated white blood cell count 
of 12.4 B/L. All other routine chemistries including measures of 
renal and hepatic function were within normal limits.
A computed tomography (CT) of the abdomen and pelvis 
revealed a small amount of intra-abdominal ascites with 
numerous ring-enhancing lesions seen throughout the 
peritoneum along the colon, particularly the sigmoid, and along 
the serosal surface of the liver. There were numerous enlarged 
mesenteric and retroperitoneal lymph nodes as well as enlarged 
right and left pericardiophrenic lymph nodes (Figure 1). 
During his hospital course, a PPD was placed and was positive 
with a 15 x 10 mm area of induration. Sputum, blood, stool, and 
urine cultures were sent for acid fast bacilli (AFB) and were all 
negative on smear. The patient’s prior CT scan of his neck and 
thorax was obtained from the outside hospital. Our radiology 
department interpreted what was called a simple cyst at the 
outside hospital as a necrotic lymph node in the right lateral 
aspect of the neck extending from the C5-C6 level through the 
supraclavicular fossa (Figure 2), and the CT thorax was notable 
for trace left pleural effusion without adenopathy or cavitary 
lesions. The patient underwent an ultrasound guided fluid 
aspiration of the cervical lymph node. 
An exploratory abdominal laparoscopy was performed 
for confirmatory diagnosis of peritoneal tuberculosis. The 
procedure revealed peritoneal studding, and multiple nodules 
An Indonesian Male with Abdominal Pain and Weight 
Loss: Abdominal Tuberculosis Presenting with Cervical 
Lymph Node Enlargement 
Leah Duke Kaye, MD and Jayne Littlejohn, MD
Figure 1. Ring-enhancing lesion on the serosal surface of the 
distal transverse colon measuring 2.4 x 2.1 cm (red arrow)
Figure 2. 39.1 mm X 46.7 mm mass (red arrow) along the right 
lateral aspect of the neck extending from the C5-C6 level through 
the supraclavicular fossa
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were noted on the anterior abdominal wall. Biopsy of the lesions 
revealed a caseous exudate in the operating room. Peritoneal 
fluid was not obtained due to the minimal ascites. Surgical 
pathology reported necrotizing granulomas, and an acid-fast 
stain identified AFB. The AFB culture sent from the OR was 
positive for Mycobacterium tuberculosis complex thirty-six days 
later. The organism was susceptible to isoniazid, streptomycin, 
ethambutol, and rifampin. The aspirate of the cervical lymph 
node also grew M. tuberculosis with the same sensitivities as the 
abdominal culture. 
The patient was empirically started on a regimen of ethambutol 
1200 mgs daily, isoniazid 300 mgs daily, pyrazinamide 1500 mgs 
daily, pyridoxine 50 mgs daily, and rifampin 600 mgs daily. He 
was discharged on hospital day 11 to continue directly observed 
therapy as an outpatient with the Department of Public Health.
Discussion
Approximately one-fifth of tuberculosis (TB) cases in the United 
States are purely extra-pulmonary. Of these, approximately 
4.9% are peritoneal. The odds of presenting with extra-
pulmonary tuberculosis versus pulmonary tuberculosis are over 
15 times higher for females, Asians, foreign-born residents, 
and healthcare workers, with 81% of cases seen in nonwhite 
racial/ethnic groups and 15% of cases seen in patients born in 
Southeast Asia. Unlike pulmonary or disseminated TB, there are 
not strong associations between extra-pulmonary tuberculosis 
and age, homelessness, excess alcohol use, or HIV status. 
Both extra-pulmonary and pulmonary tuberculosis cases have 
decreased in the U.S., but extra-pulmonary cases have decreased 
less—leading to an increase in extra-pulmonary tuberculosis as 
a proportion of total cases. In 1962, only 7.6% of tuberculosis 
cases were extra-pulmonary; in 2006 that number had increased 
to 21%.1
The common presenting symptoms of abdominal TB are 
anorexia, fever, weight loss, and abdominal pain/tenderness.2,3,4 
More than 70% of patients have symptoms for more than four 
months before their diagnosis is actually established.5,6 The most 
common finding on physical exam is ascites.7 Other common 
findings include an abdominal mass, “doughy” abdomen, and 
hepatomegaly.2,4 Routine labs are generally unremarkable except 
for a mild to moderate normocytic, normochromic anemia.4 
CT of the abdomen, while not necessarily diagnostic, can be 
extremely helpful in suggesting the diagnosis of abdominal 
tuberculosis. Ascites, peritoneal lesions, and lymphadenopathy 
are common findings seen in these patients.8 More specific 
features are free ascites, thickened strands with crowded 
vascular bundles within the mesentery, smudged pattern of 
omental involvement, and smooth, uniform thickening of 
the peritoneum.10 The commonest form of extrapulmonary 
tuberculosis is scrofula, also known as cervical lymphadenitis.9
A number of tests are available to attempt to make the diagnosis 
of abdominal tuberculosis, including tuberculin skin testing, 
ascitic fluid analysis, ascitic culture, and ascitic adenosine 
deaminase levels. A PPD is positive in approximately 70% of 
patients, but a negative test cannot exclude the diagnosis.11 
Peritoneal tuberculosis can be considered in any patient with 
unexplained ascites with a serum albumin-ascites gradient 
(SAAG) less than 1.1 g/dL. More than 95% of patients have a 
protein content over 3.0 mg/dL.12 An attempt should be made 
to perform an acid-fast smear of ascitic fluid, as well as ascitic 
culture. However, diagnostic yield for acid-fast bacilli seen on 
smear is reported to be between 0-6%4,13 and a positive culture 
is achieved in less than 20% of cases.10 Moreover, culture can 
take up to 6-8 weeks to grow, making it a less attractive option. 
Another approach to ascitic fluid involves the measurement of 
adenosine deaminase (ADA) levels, an enzyme necessary for 
differentiation and growth of T cells. A level of ascitic ADA over 
39 IU/L has a 100% sensitivity and 97% specificity in patients 
without cirrhosis.14 
If the above tests are insufficient to diagnose tuberculous 
peritonitis, exploratory laparoscopy or laparatomy, preferably 
with peritoneal biopsy, becomes the next step. A visual diagnosis 
upon seeing visceral and parietal peritoneum studded with 
multiple whitish nodules, enlarged lymph nodes, “violin-string” 
fibrinous strands, and omental thickening can be diagnostic in 
95% of cases.7,15 Upon visualizing lesions, a targeted biopsy is 
positive for acid-fast bacilli in up to 74% of patients and reveals 
caseating granulomas in up to 100% of patients.11,16
Initial treatment involves the same approach as pulmonary 
tuberculosis, with at least a 4-drug regimen until sensitivities 
can be determined. Conventionally, therapy involves rifampin, 
isoniazid, pyrazinamide, and ethambutol for at least 2 months, 
and therapy that continues for 6 months total that may use less 
drugs if sensitivities allow. Treatment may continue in some 
cases for 12-18 months.12 Fever generally resolves within one 
week of the start of anti-tuberculosis treatment; over 90% of 
patients have improvement of their ascites in a few weeks.17 
Some research suggests the addition of methylprednisolone 
therapy for one month leads to earlier improvement of ascites 
and abdominal pain as compared to patients who do not receive 
the steroid.17 Prednisone treatment also been suggested for 1-3 
months during the initial treatment as a means of reducing late 
complications from adhesive disease, such as chronic abdominal 
pain and bowel obstruction.18
Surgical approach to treatment was more popular before 
antitubercular drugs were available, often involving a right 
hemicolectomy due to frequent involvement of the ileocecal 
valve. However, with the development of available pharmaco-
therapy, this approach has generally fallen out of favor. If the 
patient develops strictures from the disease, stricturoplasty is an 
option; if there are a very high number of strictures, resection 
may be performed.12 However, even in the case of strictures, 
some reports suggest up to 70% of strictures may completely 
resolve with conventional antituberculosis therapy alone.19 In 
light of these reports, even patients with strictures should likely 
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be given a trial of anti-tubercular therapy before surgery is 
considered. 
The outcome of treated abdominal tuberculosis appears to 
depend heavily on the time between symptom onset and 
treatment. There are reports of up to 60% mortality rate if 
treatment is not started within 30 days of presentation, perhaps 
due to excessively advanced disease.4 The presence of cirrhosis 
is also an important prognostic factor. In one study, 16% of 
non-cirrhotics versus 48% of cirrhotics were not diagnosed 
with abdominal tuberculosis until death.4 This may be due to 
increased difficulty of diagnosis in cirrhosis, and underscores 
the importance of maintaining a high index of suspicion for 
abdominal tuberculosis.
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